Form 4: Nature's Sunshine Exec Gains Shares, Pays Taxes

Sentiment:

Insider Transaction Report


Nature's Sunshine Products' EVP and General Counsel, Nathan G. Brower, acquired 3,243 common shares through RSU vesting and disposed of 985 shares for tax obligations.

Summary

  • Nathan G. Brower, Executive Vice President and General Counsel of Nature's Sunshine Products Inc. (NATR), reported transactions on November 4, 2025.
  • Acquired 1,008 common shares resulting from a July 21, 2022, performance-based restricted stock unit (RSU) grant.
  • Acquired an additional 2,235 common shares from an April 20, 2023, performance-based RSU grant.
  • Both RSU vestings were triggered by the achievement of an adjusted EBITDA milestone of $46.2 million over a rolling 12-month period.
  • Disposed of 285 common shares and 700 common shares (totaling 985 shares) at a price of $13.75 per share to cover tax obligations related to the RSU vestings.
  • Following these transactions, beneficial ownership stands at 50,535 common shares.

Sentiment

Score: 7

Explanation: The vesting of performance-based restricted stock units indicates the company met a significant adjusted EBITDA milestone, which is a positive operational indicator. The subsequent sale of shares for tax purposes is a routine event following RSU vesting and does not reflect negatively on company performance.

Positives

  • Achievement of an adjusted EBITDA milestone of $46.2 million over a rolling 12-month period, leading to the vesting of performance-based restricted stock units, indicates strong operational performance.
  • The vesting structure includes a future vesting component, with half of the target vesting one year after the milestone achievement, aligning executive incentives with long-term company performance.

Negatives

  • A total of 985 common shares were disposed of to cover tax obligations, which represents a reduction in direct ownership by the reporting person.

Future Outlook

Half of the target shares from the performance-based restricted stock unit grants will vest one year following the achievement of the adjusted EBITDA milestone, indicating a future vesting event.

Industry Context

This Form 4 filing details a routine insider transaction related to executive compensation, specifically the vesting of performance-based restricted stock units. It does not provide broader industry trends or competitive analysis.

Stakeholder Impact

  • Shareholders: The achievement of a key financial milestone ($46.2 million adjusted EBITDA) and the vesting of performance-based executive compensation may be viewed positively, indicating management's alignment with company performance.
  • Employees: No direct impact on employees is mentioned in this filing.

Next Steps

  • The remaining half of the target shares from the performance-based restricted stock unit grants will vest one year following the achievement of the adjusted EBITDA milestone.

Key Dates

DateDescription
07/21/2022Date of performance-based restricted stock unit grant to the reporting person.
04/20/2023Date of performance-based restricted stock unit grant to the reporting person.
11/04/2025Transaction date for RSU vesting and tax-related share dispositions.
11/06/2025Date the Form 4 was signed by the reporting person.

Recommendation

hold

This Form 4 reports a routine insider transaction involving the vesting of performance-based restricted stock units and subsequent tax-related share sales. While the achievement of an EBITDA milestone is a positive operational sign, this filing alone does not provide sufficient new information to warrant a change in investment recommendation. It confirms executive compensation structures and performance incentives are functioning as intended, but does not introduce new fundamental data to alter a long-term investment thesis.

Keywords

Nature's Sunshine Products, NATR, Form 4, insider transaction, executive compensation, restricted stock units, RSU vesting, EBITDA milestone, beneficial ownership

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.